DUBLIN--(BUSINESS WIRE)--The "Global Active Implantable Medical Devices Market Size, Share, Development, Growth and Demand Forecast to 2023" report has been added to Research and Markets' offering.
The global active implantable medical devices market is expected to witness a CAGR of 8.0% during 2017 - 2023, and is estimated to reach $28,878.6 million by 2023.
Technological advancements, increasing prevalence of cardiovascular diseases, increasing healthcare expenditures and rising research and development activities are the major factors driving the growth of the global active implantable medical devices market. High cost of implantable medical devices and unfavorable reimbursement policies are key challenge limiting adoption of active implantable medical devices solutions.
The demand for active implantable medical devices is increasing due to increasing prevalence of cardiovascular diseases and increasing incidences of neurological disorders. Cardiovascular disease is the leading cause of premature death around the world. Implantable cardioverter defibrillators and implantable cardiac pacemakers are the key medical devices used for the treatment of different cardiovascular conditions. High prevalence of cardiovascular diseases depicts increased demand for these devices. According to the World Health Organization WHO, globally, around 17.5 million people died due to cardiovascular diseases in 2012, while the number is expected to reach 23.3 million by 2030.
Boston Scientific Corporation
Biotronik Se & Co. Kg
William Demant Holding A/S
Sonova Holding Ag
Key Topics Covered:
1. Research Background
2. Research Methodology
3. Executive Summary
5. Market Size And Forecast By Product
6. Market Size And Forecast By Geography
7. Competitive Landscape
8. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/pv6pjx/global_active